2021-01-12," <Research Report>M Stanley's Latest Ratings, TPs on CN Drugmakers (Table)  "
2021-01-12," <Research Report>M Stanley Most Upbeat on Innovative Drug, Biotech Names; Top-picks WuXi Bio, Hansoh Pharma, Innovent Bio with TP Revision "
2021-01-06,   《HKEx》- 02269 WUXI BIO - Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2020 
2021-01-06, HSTI Busts Peak; Meituan/ Kingsoft/ SMIC/ JD/ Weimob Hike Over 4%-8% 
2021-01-06, Returns May Vary a Lot for 'Wrong Bet'; CN Telecoms Should Wait & See on Variables  
2021-01-06, <Research Report>Daiwa Adds WUXI BIO (02269.HK) TP to $118; Rated Buy 
2021-01-05, *Daiwa Adds WUXI BIO (02269.HK) TP to $118; Rated Buy  
2021-01-05," HSI Once Reclaims All Over-300-pt Loss; HKEX, Mengniu Drift Higher by Over 2%-3.5% "
2021-01-05," US Stocks Plummet; Shall Eye on HSI Support at 27,000 "
2021-01-05," US Bourses Rattle to End Lower; HSI May Hail Support at 27,000 "
2020-12-31," WUXI BIO (02269.HK) Substantial Shareholder Cuts Over 100M Shrs, Cashing in Over $9.8B "
2020-12-30,"   《HKEx》- 02269 WUXI BIO - INSIDE INFORMATION - 
PLACING OF EXISTING SHARES BY
SUBSTANTIAL SHAREHOLDER "
2020-12-30," <Review>Top 5 Strongest, Weakest HSI Constituents in 2020 (Table) "
2020-12-28," HSI Gain Sharpens to Over 500 Pts to Cross 27,000; HKEX Up Almost 3% to Mark New High  "
2020-12-23," HSI Once Widens Upswing to Over 300 Pts to Surpass 26,900; Mengniu, Wuxi Bio Bust Peaks "
2020-12-23, CN Medical Insurance Drug Catalog Tweaked; 14 Exclusive Drugs' Avg Price Cut by Over 43% 
2020-12-22," <Research Report>C Suisse Hikes WUXI BIO (02269.HK) TP to $107, Rated Outperform "
2020-12-22," *C Suisse Hikes WUXI BIO (02269.HK) TP to $107, Rated Outperform "
